Table 3 Medical cost and hospital utilization for inpatients with hemophilia
Items | Hemophilia A | Hemophilia B | p-value | |
|---|---|---|---|---|
Total medical cost, RMB | Median | 8140.78 | 19347.76 | <0.001 |
IQR | (2538.15-22635.83) | (7672.97-59978.5) | Â | |
Total medication cost, RMB | Median | 4193.20 | 13700.44 | 0.001 |
IQR | (583.7-17357.12) | (2738.10-59356.33) | Â | |
% of total cost | 85.85% | 92.24% | Â | |
Total coagulation factor cost, RMB | Median | 1047.00 | 7128.00 | 0.012 |
IQR | (0-14220.8) | (0-53882) | Â | |
% of total cost | 76.86% | 86.68% | Â | |
Non-pharmacy cost, RMB | Median | 1301.06 | 1735.61 | 0.622 |
IQR | (83-4090.6) | (0-5832.91) | Â | |
% of total cost | 14.42% | 7.76% | Â | |
Number of hospitalizations, n | Median | 1.00 | 1.00 | 0.259 |
IQR | (1-2) | (1-5) | Â | |
Length of stay, days | Median | 7.00 | 9.00 | 0.033 |
IQR | (3-15) | (4-16) | Â | |